George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
I urge all members of this bb to go on Feedback’s twitter and LinkedIn pages and leave polite messages for Tom asking what is going on with regards to his investor presentation he gave in February and why there have been no tangible results. Investors have waited long enough he needs to know investors are not impressed with his performance. There has to be accountability towards shareholders and at the moment this is the only means there is to let him know the frustration that investors feel.
Agree with your assessment Private Ryan. I have resorted to leaving posts both on Feedback’s Twitter and LinkedIn page with a hope that Tom can be more candid with investors. If more private investors do this and put pressure on him perhaps things will move more quickly and become more transparent. He has consistently talked up the situation this year without providing the relevant results and shareholders need to hold him to account.
I think the slowness with regards NHS procurement is not in his hands. But having worked in the NHS he would be aware of all this.
The Sampurna adventure is something else that seems to be progressing very slowly. They have been running the pilot for nearly a year. Why are other centres not signed up yet.
The only thing they seem to do atm is release endless tweets. You wonder what the whole team does on a day to day basis.
Hopefully the QVH contract will be awarded soon and other contracts with other CDCs will follow. The benefits of bleepa have been demonstrated like you said it needs a centrally made decision to implement it.
I will post the link to the second meeting when it becomes available. I think they are discussing the way forward based on the evidence they have heard so far.
If Tom’s calculations per 10k patients are correct then since CDCs were set up they have diagnosed 3.5 million patients so saving if bleepa had been implemented in every CDC saving would be £500-600M plus added efficiency. If the civil service can work out this simple calculation and direct things centrally then perhaps things will start moving.
Tom gets to speak about an hour into discussion. He makes a good case for bleepa technology as utilised at QVH. It seems the slow progress for Feedback has been in budget allocation for digital solutions and the deployment of relevant money for that solution with it often being used in other areas. He made the point that the system at QVH releases £1.7M per 10,000 patients seen as well as improving efficiency. If the decision makers can see that by actually implementing bleepa they are saving the nhs money then perhaps they will make the investment. There seemed to a general agreement on the APPG that digital infrastructure and investment in that area was important but just how quickly that will take place was not really mentioned. The contract agreements between private providers and nhs also needs updating according to what I heard.
Looking forward to next session tomorrow and its publication later in the week.
Here is the link to 21st June meeting with YouTube link of whole discussion. Just listening to it now.
https://www.rcr.ac.uk/posts/appg-diagnostics-hears-experts-during-first-roundtable-two-community-diagnostic-centres
Looks like July will be an important month for recommendations to Secretary of State for health on way forward for CDC’s. Hopefully decisions will be made on digitisation for centres.
https://www.rcr.ac.uk/sites/default/files/documents/appg_for_diagnostics_activity_programme_fy23_24.pdf
PR I think the next time we will hear from Tom will be at the next investor meet. You could always message him in the meantime as a concerned investor to see if he gives a response. But the current s/p is a reflection on his performance during H1. I see via responses on LinkedIn that fund managers are keeping a close eye on proceedings. He is yet to give a return on the placing offer that was 140p.
It’s clear from the data that bleepa is an effective tool in reducing referral times. Time for management to convert this into sales contracts.
https://twitter.com/fbkmed/status/1673979551272124418?s=46&t=v-tjWz7Ch513H3G09ffG9g
A little more information on digital transformation
https://transform.england.nhs.uk/digitise-connect-transform/our-strategy-to-digitise-connect-and-transform/
There was no mention of the pilot in Odisha but on page 37 under ‘way forward’ they recommend the use of AI enabled handheld or portable X-ray devices to be used where TB is confirmed. This may lead to use of bleepa box and qure.ai to manage X-ray screening.
https://tbcindia.gov.in/WriteReadData/l892s/5646719104TB%20AR-2023_23-%2003-2023_LRP.pdf
It’s clear that there is impetus to bring about further digitisation of NHS with savings in efficiencies recognised.
https://htn.co.uk/2023/06/19/the-role-of-digital-in-the-2023-mandate-for-nhs-england/
Interesting Tom highlights opportunities for bleepa in the immediate and long term recovery with assistance from UK export finance. This ties in with my comments concerning aid to Ukraine.
https://www.linkedin.com/posts/drthomasoakley_a-fantastic-uk-ukraine-business-reception-activity-7077559833645707265-MZkD?utm_source=share&utm_medium=member_ios